alexa The Impact of Adjuvant Chemotherapy Initiation Time on
ISSN: 2476-2261

Journal of Oncology Translational Research
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

The Impact of Adjuvant Chemotherapy Initiation Time on the Outcome of Cancer Breast

To read the full article Peer-reviewed Article PDF image


Purpose: To identify the optimal initiation time to chemotherapy (TTC) after definitive surgery for breast cancer patients in terms of overall survival (OS) and disease-free survival (DFS), also to identify the main causes of chemotherapy delay at department of Clinical Oncology and Nuclear Medicine at Ain Shams University Hospitals. Patients and Methods: A retrospective Study including a population of 300 patients with non-metastatic breast cancer received adjuvant chemotherapy at time interval Between January 2007 till December 2011 using database from the department of Clinical Oncology and Nuclear Medicine, Ain Shams University Hospital. Chi-Square test and Kaplan- Meier method were used. Results: Among the studied population, the mean age at diagnosis was 50 years and the median TTC was 5 weeks. Compared with patients receiving chemotherapy earlier than 4 weeks from definitive surgery, there was no adverse outcome as regards the OS and DFS among those with TTC of 4 to 8 weeks, 8 to 12 weeks or more than 12 weeks with non-significant P values (0.67 and 0.9 respectively). Factors associated with chemotherapy delay included sociodemographic problems among rural patients, long residential distance to institution, system related causes as late referral, governmental insurance support and long waiting lists for diagnostic imaging. Conclusion: Adjuvant chemotherapy is equally effective up to 12 weeks after definitive surgery with similar survival benefit among breast cancer patients even those with high risk factors.


Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version